# OnCo record paper-todo-g47delta-glioblastoma-natmed-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-todo-g47delta-glioblastoma-natmed-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-todo-g47delta-glioblastoma-natmed-2022" ;
  schema:name "Todo 2022: the triple-mutated herpes virus that became Japan's first approved oncolytic virus"@en ;
  schema:description "Nineteen people with a brain tumour that had come back after radiotherapy and chemotherapy were given repeated injections of an engineered herpes virus, and more of them were alive at one year than expected."@en ;
  schema:url <https://onco.cc/key-papers/paper-todo-g47delta-glioblastoma-natmed-2022/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41591-022-01897-x>, <https://pubmed.ncbi.nlm.nih.gov/35864254/> ;
  schema:sameAs <https://doi.org/10.1038/s41591-022-01897-x> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Todo T, Ito H, Ino Y, et al." ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/oncolytic-virus/> ;
  onco:people <https://onco.cc/people/tomoki-todo/> ;
  onco:journals <https://onco.cc/journals/nature-medicine/> .